HIV Nutrition
News Update
Electronic Newsletter Archive
Issue Two, Number Two
|
|
|
|
|
Archive
- Main Menu
|
|
HIV Nutrition News Update - Iss. 2, No. 35
Aug 30, 2002
HIV/AIDS Incidence
Throughout the world, 25 million people have died of AIDS including
three-million people who died last year. Estimated worldwide HIV infections
are now 47,992,821.
Women continue to make up a larger share of AIDS cases particularly in
Massachusetts. (1) African American and Latina women constitute 75% of
all female AIDS cases.
As noted in our two-part article on HIV and Women, in
Issues
12 and 13 of the HIV ReSource Review, women typically have a more difficult
time getting health care and caring for themselves in general. Many women
do not even know that they carry the virus. Minority women continue to
be stigmatized and have difficulty accessing services. (2)
A recent report from the Hopkins
HIV Report highlights gynecological problems and differences
in viral load, disease progression and metabolic problems.
By the year 2010, 11 African countries will have life expectancies of
only 30 years. (3) As far as stemming the incidence of HIV, there is a
small grain of hope on the horizon. AIDS researchers are currently working
on a vaccine that may elicit antibodies that block the infection of multiple
HIV virus strains. (4)
Sources
1. LeBlanc S. Women Making Up a Larger Share of AIDS Cases. AP;
21 Aug 2002.
2. Stapp K. Black, Latina Women With HIV Often Fall Through Cracks.
Inter Press Service, 26 Aug 2002.
3. AIDS Epidemic Predicted To Continue Its Advance On Globe. The Nations
Health. American Public Health Association,
Sept 2002; 32(7):1,8.
4. Promising Multi-Strain HIV
Vaccine Candidate Emerges; 21 Aug 2002. University
Of Maryland Biotechnology Institute.
Nutrition And HIV/AIDS
A number of articles on nutrition and HIV/AIDS are online for HIV-positive
people at the Positively
Aware web site. These include: Update on Micronutrient Needs in
HIV, Treating Unintentional Weight Loss: An Important Piece of the
HIV Puzzle, Diarrhea...Again? Treatment Options for Medication- Induced
Diarrhea, Nutrition and Lipodystrophy, Eating for Exercise,
and Drug Nutrient Interactions and HIV.
HIV ReSources Web Site
The HIV ReSources Web Site is updated.
New pages include:
HIV, Nutrition & The Internet
Slide Show
HIV
Nutrition Discussion List
Updated pages include:
Wasting And Weight Loss Information
Why Be Tested For HIV?
National HIV Nutrition Guidelines - Testimony
Search Engines
Food Safety Resources
|
|
| Return to Top |
HIV Nutrition News Update - Iss. 2, No. 34
Aug 23, 2002
Recalls And Health Fraud
Products containing the undeclared prescription drug ingredients Alprazolam,
Indomethacin, Ethinyl Estradiol, and/or DES have been recalled both nationwide
and internationally.
The Food and Drud Administration (FDA) has warned a Baton Rouge, Louisiana
physician to stop marketing Dr. Wahid's Herbal Remedy (a syrup) for terminal
illnesses. Patients using the syrup were required to sign a document which
stated that, "This offer is for patients that are diagnosed with a terminal
illness only. I have ____ illness and have tried everything else and now
taking this remedy. . . . I also feel that there is no other treatment
that will help me." The FDA also ordered T-Up Inc. of Baltimore and Astec
Biologics of Hanover, PA to stop
illegally marketing aloe vera treatments. Issue 4 of the HIV ReSource
Review highlighted this complementary treatment,
which is marketed for a wide variety of aliments and as an immune system
booster. Company principals are now serving prison terms for fraudulently
peddling an intravenous mixture containing aloe vera. Some patients were
billed up to $18,000 for a two-week treatment of intravenous aloe vera
that they received in either the Bahamas or Mexico. Bottled combinations
of unapproved aloe vera, which may cause loose stools in users, are marketed
by numerous companies.
Australia recently issued a recall of medicinal products that contain
kava. Read about it at the Medline Plus
Health Information web site.
For additional information on recalls and warnings visit the Consumerlab
web site.
Working with the FDA, the Federal Trade Commission recently issued a
new health fraud brochure called 'Miracle'
Health Claims: Add a Dose of Skepticism. The brochure lists signs of
fraudulent health claims such as:
* Statements that the product is a quick and effective cure-all or diagnostic
tool for many ailments.
* Statements that suggest the product can treat or cure diseases.
* Promotions that use words like "scientific breakthrough," "miraculous
cure," "exclusive product," "secret ingredient" or "ancient remedy."
* Text that uses impressive-sounding terms.
* Undocumented case histories or personal testimonials by consumers
or doctors claiming amazing results.
* Limited availability and advance payment requirements.
* Promises of no-risk "money-back guarantees."
Substance Abuse & HIV
Previous issues of the HIV Nutrition News Update have focussed on substance
abuse and people living with HIV. The July 2002 Hopkins
HIV Report features an article on substance abuse and notes that substance
abuse can play a major role in HIV transmission even among non-injection
drug users. Although the article does not address nutritional issues, the
information compliments Issue
24 and Issue 25 of HIV ReSource
Review, which does address nutritional issues of substance abuse.
|
|
| Return to Top |
HIV Nutrition News Update - Iss. 2, No. 33
Aug 16, 2002
Product Labeling Change
Product labeling has been changed for AGENERASE (amprenavir) Capsules
and AGENERASE (amprenavir) Oral Solution to reflect new precautions related
to use of Agenerase with Methadone, and with oral (hormonal) contraceptives.
Methadone: Coadministration of amprenavir and methadone can decrease
plasma levels of methadone. AGENERASE may be less effective due to
decreased amprenavir plasma concentrations in patients taking these agents
together. Alternative antiretroviral therapy should be considered. Dosage
of methadone may need to be increased when coadministered with AGENERASE.
Oral contraceptives: (Ethinyl estradiol/norethindrone) Those taking
AGENERASE should be instructed not to use hormonal contraceptives because
some birth control pills (those containing ethinyl estradiol/ norethindrone)
have been found to decrease the concentration of amprenavir. This
may lead to loss of virologic response and possible resistance to AGENERASE.
Alternative methods of non-hormonal contraception are recommended.
Complete
Agenerase label
More on the XIV International AIDS Conference
Coverage of the XIV International AIDS Conference includes
Medscape
Conference Coverage, based on selected sessions including Dr. Kotler's
update on lipodystrophy, the Report from AIDS2002
Nutrition and HIV satellite and the full list of conference articles
from Health and Development Networks.
The Health and Development Networks also web site includes links
to eForums and various articles on HIV/AIDS.
Kava Products Banned in Germany
As noted in Issue
21 and Issue 22
of the HIV ReSource Review, numerous people with HIV use complementary
treatments including kava. In our December 21, 2001 HIV Nutrition News
Update we noted that dietary supplements containing kava are linked to
serious hepatotoxicity. Recently the German Federal Institute for Drugs
and Medical Devices (BfArM)
canceled the registrations of products with significant amounts of kava
kava (Piper methysticum) because of the risk of liver damage. The decision
was based on reports of more than 40 adverse reactions. Although it is
unknown whether the use of U.S. dietary supplements with kava poses similar
public health concerns, it appears prudent to avoid using kava-containing
products.
The BfArM web site may be of interest to those wishing to see press
releases such as the one on herbal medicinal products and St. John's wort
and presentations on herbal and other complementary therapies from professional
meetings.
Satellite Teleconference on Food Safety
The Food and Drug Administrations "Innovative Food Safety Grants to
State and Local Agencies: A Showcase of the Outcomes is a satellite
teleconference designed to help people learn about innovations in food
safety education. The broadcast took place on September 26, 2002 and was
geared toward enhancing food safety in the retail setting to prevent foodborne
illnesses and deaths. It featured results of the Innovative Food Safety
Grants from FY 1999 and 2000.
Food establishments and others interested in promoting safe food practices
can visit the FDA web site to get more
information about the satellite coordinates, to register your location
as an Open Site, or to see if there is an Open Site near you. |
|
| Return to Top |
HIV Nutrition News Update - Iss. 2, No. 32
Aug 9, 2002
XIV International AIDS Conference Information
Abstracts from the XIV International AIDS Conference are available
through the official web site and may be viewed using Internet Explorer.
Other reports are available on HIV
InSite's Conference Coverage page and Medscape's web site including
"Liver Function Tests Independently Predict
Survival".
Diabetes
Short-term treatment with vitamin C and vitamin E may help to lower
the risk of progressing to end-stage renal disease in Type 2 diabetic patients
with elevated urinary albumin excretion rates. (1) HIV ReSource Review
subscribers may refer to Issue
27 and Issue
28 for additional information on HIV/AIDS and glucose abnormalities
including diabetes.
Recent results from the 3-year Diabetes Prevention Program report a
sharply lower risk for Type 2 diabetes with diet and exercise changes.
(2) Thirty minutes of exercise each day along with changes in diet resulted
in a five to seven percent loss of body weight. Treatment with Glucophage
(covered in Issue 27 of the HIV ReSource Review) also resulted in a decreased
risk of Type 2 diabetes.
Although the study group was not reported to be HIV-positive these results
may be useful to those HIV-positive people who have an increased risk of
diabetes due to highly active antiretroviral therapy.
Sources
1. Gaede P, Poulsen HE, Parving HH, Pedersen O. Double-blind, randomised
study of the effect of combined treatment with vitamin C and E on albuminuria
in Type 2 diabetic patients. Diabet Med 2001 Sep;18(9):756-60.
2. Diet, Exercise Delay Type 2 Diabetes. FDA Consumer Magazine 2002;
35(5):10-11.
Conference Information
AIDS Nutrition Services Alliance (ANSA), Project Angel Food, AIDS Project
Los Angeles and Desert AIDS Project held Client Day 2002 at the Renaissance®
Hollywood Hotel on Thursday, September 12, 2002. The fun-filled, free and
educational program for people with HIV/AIDS was held in both Spanish and
English, and focused on aspects important for the entire being. Speakers
covered subjects such as medical benefit updates, buying food on a tight
budget, cooking classes, the mind-body connection and safe ways to lose
weight. Breakfast and lunch was provided. For more information on future
conferences, visit ANSA’s web site.
Nutrition & Exercise Workshops were held at various locations between
August 16, 2002 through March 1, 2003. During the two-day workshops, Dr.
William Evans and Nancy Clark, MS, RD provided practical tools for all
health professionals interested in exercise and nutrition. For further
information on other sessions visit the Web Site above. |
|
| Return to Top |
HIV Nutrition News Update - Iss. 2, No. 31
Aug 2, 2002
HIV ReSources Web Site
The HIV ReSources Web Site is updated.
Updated pages include:
Information on HIV-positive Women & Children
Conference Information
Books on HIV Prevention and Education
Books on Complementary Treatments
Agenerase Alert
XIV International AIDS Conference Nutrition Highlights
Abstracts from the XIV International AIDS Conference in Barcelona,
Spain are available. Selected poster presentation abstracts are available.
The site is viewed best using Internet Explorer version 5.0 or higher.
The conference offered limited exposure to nutritional issues. Some
abstracts highlighted the need for nutritional services including nutrition
education to help people living with HIV optimize medications and deal
with their adverse effects, avoid malnutrition and increase quality of
life. (1-11) Presenters noted the importance of the need for research to
determine foods that are essential for the management of HIV/AIDS. (9)
Prescribing specific meal plans to compliment medications used to treat
opportunistic infection would be helpful as well. For people lacking access
to HIV medications, African presenters noted the success of a program that
incorporated a holistic approach to disease management based on nutrition
and education. (12)
One abstract noted the need for Day Care Centers along with a focus
on the use of body weight as an indicator for needed nutritional services.
(6) Presenters stressed the need for optimal nutrient intake to help HIV-positive
people meet their increased need for vitamins, minerals, calories and protein.
One thing that is becoming increasingly clear is that nutrition must be
incorporated into programs geared towards helping people with HIV. As noted
by one presenter, health care providers must accept their responsibility
for providing nutritional services including medical nutrition therapy
to delay disease progression and increase the overall well being of HIV-positive
people. Linking to health care programs for the general population may
be more successful than developing specific initiatives for people with
HIV. (7)
Sources
1- Fields-Gardner C, Hershey J, Roberts L, Weingartner K, Khanna P.
The World Intitiative for Soy in Human Health (WISHH) addresses nutritional
needs of HIV-infected and affected communities; abstract no. MoPeF4127.
2- Bassichetto KC, Piloto HF. A nutritional guideline to outpatient
clinic care for adults living with HIV/AIDS; abstract no. ThPeF8212.
3- Hernandez V. Treatment and care support found in the model of attitude,
medications, exercise, and nutrition (amen). abstract no. ThPeF8201.
4- Pieribone DL, Herman L, Singer S, Fenton M, L'Heureux J. Optimizing
nutrition status through education in food pantry clients. ThPeF8208.
5- Lakshmikanthan RupaApsop S. Nutrition-an essential co-therapy; abstract
no. WePeF6846.
6- Vadrevu1 R, Vadrevu L, Prasada Rao DVS, Saple DG. Out patient care
program for PLWHA in resource poor setting - One year experience without
external aid; abstract no. WePeF6772.
7- Pribram V, Gilbert C. A combined approach to nutrition, exercise,
and smoking cessation to reduce lipodystrophy and ill-health in people
with HIV taking HAART; abstract no. ThPeF8207.
8- Fields-Gardner C, Romeyn M, Bowers M. Development and field test
of nutrition-related assessment and treatment guidelines in pediatric HIV
infection; abstract no. WePeF6810.
9- Malakasuka1 EM, Masangi V. The impact of nutrition on HIV/AIDS clients;
abstract no. ThPeF8213.
10-Csta JAC. Corporal image and life quality: the experience of the
intervention nutritional in the care of the people living HIV/AIDS in a
specialized service in Sao Paulo city- Brazil; abstract no. ThPeF8210.
11-Alves MEF, Alves MCF, Alves RCF. Profile of the dental needs of
an urban HIV/AIDS population; abstract no. ThPeB7391.
12- Francis LK. What happens when there aren't any drugs? Living longer
and healthier with HIV; abstract no. ThPeF8226.
July/August HIV Nutrition Update Newszine
The July/August issue of HIV Nutrition Update is now available. Subscribers
with Internet access can view the issue using their assigned username and
password. Issue 37 includes
an original research article written by Brian Kineman, MA, Marcia L. Nahikian-Nelms,
PhD, RD, LD and Christina L. Frazier, PhD titled " A Pilot Investigation
of the microbial contamination of herbal supplements: Is there a risk for
immunocompromised populations?" Issue 37 also includes an informative view
of herbs used in Traditional Chinese Medicine by Richard A. Freiberg, D.O.M.,
D.Ac., A.P., Board Certified Diplomate.
In addition, it holds:
* Program Spotlight column on God's Love We Deliver located in NY,
NY;
* Update Central column with information on lipodystrophy;
* Resource Corner with leads to Internet, client and clinician resources
and free publications;
* Med Watch column on Tequin (Gatifloxacin);
* Nutrition Forum question and answer column on platelets. |
| |
| Return to Top |
HIV Nutrition News Update - Iss. 2, No. 30
July 26, 2002
Probiotics
Numerous benefits are attributed to probiotics. As noted in Issue
34 of the HIV Nutrition Update, evidence suggests that probiotics can
enhance both specific and nonspecific immune responses. Dietary consumption
of the probiotic strain Lactobacillus rhamnosus HN001 in low-fat milk appears
to enhance systemic cellular immune responses. (1) Investigators note that
it may be useful as a dietary supplement to boost
natural immunity. A nine-week study of 30 people completed by Gill
and colleagues notes enhancement of phagocytes and tumoricidal activity
of natural killer cells with Bifidobacterium lactis (2)
The researchers conclude that B. lactis HN019 may be effective for enhancing
aspects of cellular immunity in the elderly. Earlier studies reported that
dietary consumption of B. lactis HN019 can enhance natural immunity in
healthy elderly subjects after a period of six-weeks. (3)
Anecdotal reports of the usefulness of probiotic strains in lessening
diarrhea in HIV-positive people are increasing. Medscape
recently reported that probiotics may prevent antibiotic-associated diarrhea.
Although these studies do not specifically address the HIV population,
probiotics may prove to be useful for people living with HIV/AIDS.
Sources
1. Sheih YH, Chiang BL, Wang LH, Liao CK, Gill HS. Systemic immunity-
enhancing effects in healthy subjects following dietary consumption of
the lactic acid bacterium Lactobacillus rhamnosus HN001. J Am Coll Nutr
2001;20(2 Suppl):149-56.
2. Gill HS, Rutherfurd KJ, Cross ML, Gopal PK. Enhancement of immunity
in the elderly by dietary supplementation with the probiotic Bifidobacterium
lactis HN019. Am J Clin Nutr 2001;74(6):833-39.
3. Arunachalam K, Gill HS, Chandra RK. Enhancement of natural immune
function by dietary consumption of Bifidobacterium lactis (HN019). Eur
J Clin Nutr 2000;54(3):263-7.
Culturally Sensitive Care Guide
The revised HHS Health Resources and Services Administration's "Provider's
Guide to Quality and Culture" includes information to help health
care practitioners provide culturally sensitive care to minority groups.
The guide features interactive video/audio streaming of best-practice vignettes
on working with culturally and linguistically diverse patients. For more
information about the Guide, contact Len Epstein, Quality Center, Bureau
of Primary Health Care at 301/594-3803.
Conferences
WorldNutra 2002 - 3rd Annual International Conference & Exhibition
on Nutraceuticals and Functional Foods was held in San Diego, California
November 17-20, 2002. Further information
on other conferences are at their web site.
The Sixth Annual United States Conference on AIDS was held on September
19-22, 2002 at the Anaheim Hilton in Anaheim, California. For comprehensive
information on this and other conferences visit the
web site.
Atherosclerotic Disease and HIV Infection was held on Thursday, October
10, 2002 at the New York Marriott Marquis Hotel in NY, NY. For further
information on other conferences visit the
web site or contact the Office of Continuing Medical Education
at St.Luke's-Roosevelt Hospital Center via telephone at 212/523-2138. |
| |
| Return to Top |
HIV Nutrition News Update - Iss. 2, No. 29
July 19, 2002
Lipodystrophy
Recent reports note that an increase in triglycerides can predict lipodystrophy
in those patients who are taking highly active antiretroviral therapy (HAART).
(1) Increased cholesterol levels
may also have a role in predicting lipodystrophy. Interestingly, although
the Food and Drug Administration has approved a new non-invasive palm test
to measure skin cholesterol it is intended to be used along with standard
blood tests. (2)
Numerous complementary therapies are taken by HIV-positive people to
try and reduce triglyceride and cholesterol levels. These therapies include
garlic, guggul, flaxseed and fish oil supplements. As noted in previous
HIV Nutrition News Updates, garlic supplements can impede HIV medications,
particularly saquinavir. A literature review of garlic is in Issue
14 of the HIV ReSource Review. Additional information on garlic is
at Thebody.
In our June 7, 2002 HIV Nutrition News Update we noted that guglipid
may reduce cholesterol in mice by blocking
the body's Farnesoid X Receptor (FXR), which plays a key
role in managing cholesterol levels. Readers of the HIV ReSource Review
may refer to Issue
27, which holds a comprehensive literature review on guggul. Additional
information on
gugulipid is on the Internet.
Information on flaxseed and fish oil is at Thebody.
Preliminary data reports a reduction in cholesterol levels with the
use of L-carnitine (3)
Issue
36 of the HIV Nutrition Update newszine contains a literature review
of carnitine including the use of carnitine in HIV-positive people.
Sources
1. Rodriguez-Guardado A, Maradona JA, Carton JA, Asensi V. Triglyceride
Increase Can Predict Lipodystrophy in HIV Patients Under Highly Active
Antiretroviral Therapy. AIDS 2002;16(10):1434-1436.
2. FDA Clears New Palm Test For Skin Cholesterol. FDA Talk Paper, T02-27;
25 Jun 2002.
3. Mauss S, Schmutz G. L-Carnitine in the treatment of HIV-associated
lipodystrophy syndrome. HIV Med 2001 Jan;2(1):59-60.
Tuberculosis (TB)
In our June 14, 2002 HIV Nutrition News Update we noted a report
that people with TB may benefit by adding both vitamin A and zinc to
their anti-TB medication. People living with HIV however, would be wise
to consult with their physician or an HIV-savvy nutrition professional
before adding any dietary supplements to their daily regimen. As noted
in a literature review of zinc published in Issue
16 of the HIV ReSource Review, too much zinc can depress the immune
system. Although this research must be confirmed in larger studies, it
is a welcome promising development that may allow physicians to reduce
the amount of anti-TB drugs that must be taken by TB patients. Online resources
for TB include the
HIV InSite Knowledge
Base, MMWR
and the MEDLINEplus
web site.
HIV/AIDS Continues To Increase Especially In Young People. About 14,000
new HIV infections occur every day. Approximately 5-10 % of the people
with AIDS are infected via blood transfusions. More than a third of the
40 million people living with HIV today are under the age of 25. Young
people ages 15 to 24 account for half of all new infections among adults.
Sadly, most of the world's young people have
no idea how HIV/AIDS is transmitted or how to protect themselves from
the disease. New projections indicate that the number of young people living
with HIV/AIDS will increase to 21.5 million by the end of the decade.
View all the Kaiser Daily HIV/AIDS
Reports, search the archives, or sign up for email delivery.
Source: The Tip of the Iceberg: The Global Impact of HIV/AIDS
on Youth. XIV International AIDS Conference in Barcelona, Spain:
Henry
J. Kaiser Family Foundation. |
| |
| Return to Top |
HIV Nutrition News Update - Iss. 2, No. 28
July 12, 2002
Highlights From The 14th International AIDS Conference
News from the 14th International AIDS Conference in Barcelona Spain
highlights the importance of nutrition in the care of HIV-positive people.
As food insecurity increases, the need to examine its link with HIV/AIDS
becomes more apparent. The focus on food security and nutrition is increasing
as reports of diminishing food supplies, due to decreased production and
loss of family labor, become known. Malnutrition continues in sub-Saharan
Africa where food insecurity further increases the risk of disease progression.
A declaration of commitment made last year by the United Nations General
Assembly Special Session on HIV/AIDS documents as essential the inclusion
of nutrition as a core part of any HIV-care package. As nutritional deficits
make HIV-positive people more susceptible to disease and infections, increasing
access to food is an overwhelming priority in many parts of the world.
HIV/AIDS: A Guide for Nutrition,
Care and Support was field-tested in Malawi and Uganda and developed
for community organizations. The guide helps program managers to make recommendations
on food management and nutritional issues for households affected by HIV/AIDS.
Source: Machipisa L. AIDS Posing Serious Threat to Food Security.
Inter Press Service, IPS-ONLINE, 5 July
2002. WWW: Distributed by AEGiS.
7 Jul 2002.
HIV Nutrition Education Materials
Eat up! Nutrition Advice And Food Ideas For People Living With HIV
And AIDS is a helpful guide for anyone living with HIV by nutritionist
Charlie Smigelski, RD. Visit the web
site for further information.
Dr. Mary Romeyn's Nutrition And HIV A New Model For Treatment is a "must-have"
book! It contains lots of nutrition information, vitamin and mineral recommendations.
Find it at the library, your local book store or visit HIV
ReSources book links for a reduced price.
The Complete Nutrition Education Binder is a peer-reviewed 600+ page
assortment of research articles and information on nutrition, HIV and complementary
therapies. It holds issues 1-30 of the HIV ReSource Review with more than
5,000 references and 15 handouts and clinician tools. Visit the AIDS Book
Review Journal at 2
and 1
for their review of this publication. Selected issues of the newsletter
are free at the HIV ReSources web site.
Recalls And Safety Alerts
FDA has determined that "Nicotine Water" should be regarded as an unapproved
new drug and cannot be legally marketed
as a dietary supplement.
Nature's Way Has Recalled Nettle because the product contains excessive
amounts of lead. Nettle is a common herbal supplement used for arthritis
and kidney problems and as an expectorant and pain reliever. |
| |
HIV Nutrition News Update - Iss. 2, No. 27
July 5, 2002
Diet, HIV & Heart Disease
The risk of heart disease for people living with HIV has increased
since the advent of highly active antiretroviral therapy (HAART). Studies
show that HAART, which includes a protease-inhibitor, increases the risk
of heart disease. (1) Increased dietary
intakes of fruit and vegetables are associated with reduced risks of heart
disease. Ensuring a nutritious diet can help HIV-positive people to meet
their daily nutrient requirements and decrease the risk of heart disease
as well. Investigators for the Oxford Fruit and Vegetable Study Group recently
found that an increased intake of fruit and vegetables can lead to increased
plasma concentrations of carotene, ß-carotene, lutein, ß-cryptoxanthin,
and ascorbic acid. (2) In their
six-month, randomized, controlled trial of 690 healthy participants between
the ages of 25 to 64 years old, increased consumption of fruit and vegetables
also decreased blood pressure. Since a diet with increased fruit and vegetable
consumption can lower the risk of heart disease in the general population,
people living with HIV may experience these beneficial effects as well.
A two-part article notes heart healthy food choices for HIV-positive
people in Issue 22
and Issue 23 of the
HIV ReSource Review. AIDS Community Research Initiative offers some
tips
to ensure a nutritious diet. AIDS Project Los Angeles offers It Pays
To Be Picky a guide on vitamins found in fruit and vegetables at 1
and
2. And
the
June 2002 issue of HIV Treatment
Bulletin offers Nutrition And Immunity: You Are What You Eat, The Role
Of Dietary Supplements In HIV and Using Evidence To Make Nutrition Decisions:
A Look At Zinc.
As high blood cholesterol increases the risk of heart disease, readers
may find the Third
Report of the Expert Panel on Detection, Evaluation, and Treatment of High
Blood Cholesterol in Adults (Adult Treatment Panel III) helpful. The
report summarizes the detection, evaluation, and treatment of high blood
cholesterol in adults.
Sources
1. Koppel K, Bratt G, Schulman S, Bylund H, Sandström E. Hypofibrinolytic
State in HIV-1- Infected Patients Treated With Protease Inhibitor- Containing
Highly Active Antiretroviral Therapy. JAIDS 2002;29(5):441-449.
2. John JH, Ziebland S, Yudkin P, Roe LS, Neil HAW. Effects Of Fruit
And Vegetable Consumption On Plasma Antioxidant Concentrations And Blood
Pressure: A Randomised Controlled Trial. Lancet 2002; 359(9322): 1969-74.
Conferences & Meetings
National Association of People With AIDS (NAPWA) sponsored the 5th
National Association of People With AIDS (NAPWA) Annual Conference: Staying
Alive; Rising Above on August 16-18, 2002. The conference was held in Philadelphia,
PA. Visit for additional information
on other conferences.
What Now - What Next? 4th Annual Women and HIV/AIDS Conference was held
on August 24, 2002 in Miami, FL. The conference was sponsored by the Center
For Positive Connections. For further information on this and other conferences
visit amfar.
The Los Angeles AIDS Nutrition Services Alliance (LA ANSA) meets once
every six weeks to discuss pertinent topics related to foodservice, nutrition
and HIV/AIDS in Los Angeles County. Visit the Web
Site for further information.
The ANSA Conference, 2002: Honoring Our Past - Shaping Our Future was
held in Hollywood, CA on September 12-15, 2002. This informative conference
was a treasure chest full of resources for anyone who offers nutritional
counseling, works or volunteers for a food bank or is associated with other
sources of nutritional services. This year conference planners addressed
the impact on an agency when expanding to serve populations other than
those living with HIV/AIDS. For more information on future conferences
visit the ANSA web site.
Additional conference information
|
| |
| Return to Top |
HIV Nutrition News Update - Iss. 2, No. 26
June 28, 2002
HIV ReSources Web Site
The HIV ReSources Web Site is updated. Updated pages include:
* Conference Information
* Books For People Living With HIV
* Nutrition Resources
* Books on Medications, Nutrients And Herbs
* National HIV Nutrition Guidelines
* Nutrition Related Conditions
* Nutrition & HIV Discussion Archive Page
1
* Nutrition & HIV Discussion Archive Page
2
Herbal Products Warning
As noted in Issue 21
and Issue 22 of the
HIV ReSource Review there are a variety of herbal products that are commonly
used by people living with HIV. When taking herbal products it's important
to learn about their safety, effectiveness and herb-drug interactions.
Health
Canada recently warned the general public of some Chinese herbs containing
undeclared prescription drugs. The herbal products, which contain the prescription
drugs Diethylstilbestrol, Indomethacin, and Alprazolam are made in the
U.S. by BotanicLab. They are marketed for a number of bone, muscle, and
other disorders including decreased immune system. Subscribers to this
update will recall that Botanic Lab has already recalled several products
(see the HIV Nutrition News Update of March 22, 2002) because they contained
the prescription drug alprazolam (Xanax). MedWatch offers a variety of
safety
information. Find additional warning and safety information on herbs,
supplements, and prescriptions at 1 and 2.
Sharon Herr, RD covered numerous herb-drug interactions in her two-part
article published in Issue
28 and Issue
29 of the HIV ReSource Review.
Foodborne Illness
As the temperature rises, so does the incidence
of illness from Vibrio vulnificus which is often found in raw oysters.
State officials in warm climates usually issue raw
oyster warnings for especially susceptible people such as those with
AIDS, cirrhosis, hepatitis or cancer. More than 300 infections have been
reported from Gulf Coast states. The incidence of raw oysters infected
with Vibrio vulnificus is increased in the Los Angeles area as well based
on reports during the past few years (1993-1995;1993-1996;
and MMWR;
2001;
and 2002).
Additional sources of information on Vibrio
vulnificus and other foodborne illness include the Food
Protection Program and the HIV ReSources web
site.
May/June HIV Nutrition Update Newszine
The May/June HIV Nutrition
Update has been published. The newzine issue includes:
Handout titled "Food Safety And You"
Feature on Carnitine And Acetyl Carnitine
Program Spotlight - Nutrition For Healthy Living in Boston, MA
Update Central - Diet & HIV Infection and Bone Disorders
Resource Corner - client, clinician, and free resources
Med Watch - Indinavir sulfate (Crixivan)
Nutrition Forum - question and answer column on T-cells
|
|
| Return to Top |
HIV Nutrition News Update - Iss. 2, No. 25
June 21, 2002
Vitamins, Minerals & HIV
Recent information suggests that the general population should take
one vitamin supplement per day to avoid an increased risk of chronic disease.
(1, 2) Sub-optimal intake of some vitamins is common
in the general population and in some people living with HIV as they
do not eat a diet that provides an optimal amount of all vitamins. Inadequate
intake of vitamins is linked to chronic
diseases (such as heart disease and colon and breast cancer- folate,
vitamin B6, vitamin B12; prostate cancer- vitamin E, lycopene; and osteoporosis-
calcium, vitamin D). (2) HIV infection can negatively affect many nutrients
leading to other complications. Although we do not have standard guidelines
for the supplementation of vitamins and minerals for those living with
HIV, a number of sources offer information on the use of dietary supplements.
Review "The
Role of Dietary Supplements in HIV" by George Carter of AIDS Community
Research Initiative (CRIA) and "Vitamins
and Minerals, From A to Z". Jennifer Muir Bowers, PhD, RD, CNSD discusses
natural
vitamins and minerals. Diana Peabody, RD reminds us that recommendations
should
depend on the quality of evidence that is available. Evidence noting
the use of vitamin and mineral supplements in people living with HIV is
very limited and most of it took place before the widespread use of HAART
(highly active antiretroviral therapy).
Some vitamins and minerals taken in excess can be harmful. Over- supplementation
of some micronutrients decreases immune function and may increase the progression
of HIV. For instance, an excess of zinc or iron can result in decreased
immune function. Some vitamins in excess can cause problems like nausea,
stomach cramps and diarrhea. Also, as there may be interactions between
antivirals, medications and herbs, it is vital that people living with
HIV learn more about vitamins and minerals before they take them on a routine
basis. Seeking reliable information on vitamins and minerals from health
care professionals such as physicians and registered dietitians (RDs) who
are familiar with these interactions will help individuals to avoid unnecessary
complications.
Sources
1. Fletcher RH, Fairfield KM. Vitamins for Chronic Disease Prevention
in Adults Clinical Applications. JAMA. 2002;287(23):3127-3129.
2. Fletcher RH, Fairfield KM. Vitamins for Chronic Disease Prevention
in Adults Scientific Review. JAMA. 2002;287(23):3116-3126.
HIV/AIDS Informational Newsletters
An e-newsletter on Infectious Diseases (OPINIONS
2) is now available in both html and pdf formats. The newszine considers
the efficacy of infectious disease policies and discusses alternatives.
Kaiser Daily HIV/AIDS Report is a free service of The
Henry J. Kaiser Family Foundation.
The Hopkins HIV Report is available
online.
HIV i-Base publications are on
line. Subscribe or
receive the publications by email.
Conference Information
Seafood Sense was held on September 11-13 in Lewes, DE. For additional
conference information visit
the web site.
The National Institutes of Health, American Society for Nutritional
Sciences, and National Cancer Institute sponsors Cancer Prevention conferences.
Visit the web site for additional information.
Thinking Globally -- Working Locally: A Conference on Food Safety Education,
2nd National Conference for Food Safety Educators was held on September
18-20 in Orlando, FL. Details of this USDA and HHS and other sponsored
conferences are at the web site.
Additional conference information is at the HIV
ReSources web site.
|
|
| Return to Top |
HIV Nutrition News Update - Iss. 2, No. 24
June 14, 2002
Minerals And HIV
Recently a study by Gail Shor-Posner and colleagues at the University
of Miami found that selenium supplementation at 200 µg per day may
lower the risk of mycobacterial disease, such as Mycobacterium tuberculosis,
in HIV-positive people. (1) For additional information read the February
2002 article in the Journal of Acquired
Immune Deficiency Syndromes.
Researchers at Johns Hopkins University revealed that high manganese
levels might decrease HIV's reverse transcriptase activity. (2)
This could delay the HIV virus from progressing to AIDS. United
Press International reports that this finding could lead to a new class
of medications for the HIV. Dietary supplements of zinc (15 mg) and vitamin
A (5,000 IU) may help anti-TB medications to work more effectively based
on research completed by Elvina Karyadi and colleagues in the Netherlands.
(3) The supplementation helps to boost
the immune response in these patients. Although the research still needs
to be confirmed in larger studies, adding supplements of vitamin A and
zinc may allow for a reduction in the length of the regimen and dosage
of TB medicine. Readers of the HIV ReSource Review may refer to our literature
review of zinc in Issue
16.
Sources
1. Shor-Posner G; Miguez MJ, Pineda LM, Rodriguez A, et al. Impact
of Selenium Status on the Pathogenesis of Mycobacterial Disease in HIV-1–
Infected Drug Users During the Era of Highly Active Antiretroviral Therapy.
JAIDS 2002;29:169-173.
2. Bolton EC, Mildvan AS, Boeke JD. Inhibition of Reverse Transcription
In Vivo by Elevated Manganese Ion Concentration. Molecular Cell, Vol 9,
879-889, April 2002.
3. Karyadi E, West CE, Schultink W, Nelwan RHH, et al. A Double-Blind,
Placebo-Controlled Study Of Vitamin A And Zinc Supplementation In Persons
With Tuberculosis In Indonesia: Effects On Clinical Response And Nutritional
Status. Am J Clin Nutri 75(4):720-727.
St. John's Wort and Depression
As noted in our two-part issues on botanical use among HIV-positive
people (Issue
21 and Issue 22
of the HIV ReSource Review), supplement manufacturers do not have to prove
that their products are effective or even safe before marketing them. Studies
of St. John's Wort have generally suggested that it may be useful in treating
mild to moderate depression, however experts have noted some study limitations
within these trials. A recent study on St. John's Wort showed that it was
ineffective for major depression. (1) The double-blind, randomized, placebo-controlled
trial of 340 people found that an extract of Hypericum perforatum was ineffective
against moderately severe depression. Clinical trial results were published
in the Journal of the American Medical Association. (2)
Questions and Answers: A Trial of St. John's Wort (Hypericum perforatum)
for the Treatment of Major Depression is on
the Internet. Additional trials are needed to determine if St. John's
Wort is useful for the treatment of mild to moderately severe depression.
Sources
1. Study Shows St. John's Wort Ineffective for Major Depression. FDA
Consumer. May/June 2002:8.
2. Hypericum Depression Trial Group. Effect Of Hypericum Perforatum
(St. John's Wort) In Major Depressive Disorder. JAMA 287:2801-1814, 2002.
APLA Nutrition in HIV Care Education/Training Program
Nutrition in HIV Care Education & Training Programs are held in
Los Angeles regularly. Additional information and materials are at the
APLA online web site under the nutrition
topics. Participants are required to attend all sessions on all four days
and need to successfully complete an Educational Objective Evaluation (post
test) to receive Continuing Professional Education hours and certificate
of completion.
PROCRIT Product Safety Warning
PROCRIT (epoetin alfa) is used primarily for the treatment of anemia
associated with various conditions including zidovudine treatment in HIV
patients. Ortho Biotech Products, L.P. notified pharmacists, health care
providers, and wholesalers/distributors of counterfeit
PROCRIT. Vials of PROCRIT labeled as 40,000 U/mL in four-pack boxes,
lot number P002641, expiration date: 9/03, have been found to contain active
ingredient that is approximately 20 times lower than would be expected.
It is thought that all existing inventory of AUTHENTIC lot number P002641
may have been used so any product bearing this lot number should be considered
suspect and be closely examined. A brief description of the differences
between the actual product and the counterfeit, with comparative photographs,
is provided in the Ortho Biotech letter.
In addition lot number P002384, expiration: 03/2003 has also been determined
to be counterfeit. Any product bearing this lot number in particular should
be considered suspect. |
|
| Return to Top |
HIV Nutrition News Update - Iss. 2, No. 23
June 7, 2002
Shrimp Warning
Ready-to-eat shrimp is a threat to HIV-positive people as it can contain
antibiotic-resistant bacteria. Duran and colleagues believe that contamination
could come from both the packaging process and the water that the shrimp
was grown in.
Guggul and Cholesterol
Investigators recently found that guglipid may reduce cholesterol by
blocking the body's Farnesoid X Receptor (FXR), which plays a key role
in managing cholesterol levels. (1) The researchers findings are published
in a May issue of Science magazine. (2) Readers of the HIV ReSource Review
may refer to Issue
27, which holds a comprehensive literature review on guggul. As reported
in the HIV ReSource Review, preliminary studies show that adding guggulipid
with a cholesterol-lowering diet can further reduce cholesterol. Additional
studies will attempt to determine the biochemical reasons for the cholesterol-lowering
effect. Lead investigator Nancy Urizar notes that "there is a lot out there
on the Web that we can't support". Consumers should always thoroughly research
products to find reliable information and consult with their health care
providers before using dietary supplements.
Sources
1) Natural Cholesterol Fighter Shows The Way. Baylor College of Medicine:
Houston, TX.
2) Urizar NL, Liverman AB, Dodds DT, Silva FV, et al. A Natural Product
That Lowers Cholesterol As An Antagonist Ligand for FXR. Science 296: 1703-1706;
Published online 2 May 2002.
Free Nutrition Newsletters
Nutrition
for Healthy Living
Food
For Thought
Center
for Human Nutrition Newsletter
Nutrition News Focus
Nutrition & Your Child
Conference Announcement
The Orange County Health Care Agency sponsored a Hepatitis Summit,
"Viral Hepatitis: An Emerged Epidemic" on July 18-19, 2002 at the Holiday
Inn Conference Center in La Mirada, CA. For additional information on other
conferences visit the
web site. |
|
| Return to Top |
HIV Nutrition News Update - Iss. 2, No. 22
May 31, 2002
Diabetes
As noted in previous updates and Issue
27 and Issue
28 of the HIV ReSource Review, patients with lipodystrophy are more
likely to have glucose abnormalities that can lead to diabetes. A nationwide
campaign, "Take Time to Care", sponsored by the Health and Human Services
Food and Drug Administration (FDA), the American Diabetes Association,
and the National Association of Chain Drug Stores (NACDS) has been launched
to raise women's awareness about diabetes. (1) Local pharmacies offered
free risk assessment and clinical testing, free educational materials and
a Diabetic Management Kit in 10 key cities where residents have a high
incidence of diabetes. Diabetes risk assessment events were conducted at
chain pharmacies from May 28th to June 22, 2002. Participants received
diabetes-related brochures, wallet-sized calendars, and cards with recipes
for nutritious meals in Atlanta, Baltimore, Chicago, Dallas, Detroit, Los
Angeles, Miami, New Orleans, Indianapolis and Philadelphia. The brochure
highlights the warning signs of diabetes, which include fatigue, frequent
urination, unusual thirst, extreme hunger, unusual weight loss and irritability.
Recurring skin, gum, and bladder infections, blurred vision, cuts and bruises
that are slow to heal are also potential signs and symptoms. Additional
information about the "Take
Time to Care" campaign is at the FDA web site. Consumer information
about diabetes is available through the National
Diabetes Education Program or from the American
Diabetes Association, telephone 800/342-2383. People with diabetes
are at risk for foot injuries that could lead to serious complications.
Learn five tips every diabetic should know about foot
care. As noted in an earlier update it's
important to treat people with the metabolic syndrome to prevent heart
disease. The prevalence of metabolic syndrome increases with age (2) and
clinicians screening people living with HIV should be aware of this increased
incidence in older adults.
Sources
1. Take Time To Care About Diabetes. HHS Press Release.
FDA
Press Office; 2 May 2002.
2. Ford ES, Giles WH, Dietz WH. Prevalence Of The Metabolic Syndrome
Among US Adults: Findings From The Third National Health And Nutrition
Examination Survey. JAMA
2002 Jan 16;287(3):356-9.
HIV ReSources Web Site
5/23/02-The HIV ReSources Web Site is updated.
New pages include:
* Issue 36 HIV Nutrition
Update
Updated pages include:
* Newsletters & Magazines
* HIV Nutrition News Update Electronic Newsletter Archive
* Issue Two, Number One
* Issue One
* Conference Information
* Questions and Referrals
* Newsletter Previews Menu
* Miscellaneous HIV/AIDS Topics
* Search Engines |
|
| Return to Top |
HIV Nutrition News Update - Iss. 2, No. 21
May 24, 2002
FDA Notification
Labeling information for several pharmaceutical products have changed
including numerous products noted in issues of the HIV Nutrition Update
and HIV ReSource Review. Serono, Inc. became aware of a counterfeit lot
of Serostim [somatropin (rDNA origin) for injection] (covered in Issue
11 of the HIV ReSource Review) packaged to appear as drug product lot number
S810-1A1. This is not a legitimate Serostim lot number. Preliminary information
appears to indicate that the counterfeit material may have been distributed
via the Internet. However, pharmacists should examine Serostim prior to
dispensing to ensure that the package does not note lot number S810-1A1.
Patients should also check products in their possession and return those
with the above lot number. Access the MedWatch through the FDA
web site.
AMGEN, in cooperation with the FDA, notified pharmacists and health
care providers of counterfeit EPOGEN (epoetin alfa), covered in Issue 12
of the HIV ReSource Review. Epogen is used to treat the anemia that some
patients with HIV/AIDS experience while taking AZT (zidovudine). EPOGEN
40,000 U/mL vials in ten-pack boxes, lot number P002970 with expiration
date 7/03 has been found to contain active ingredient that is about 20
times lower than would be expected for this product. Pharmacists and health
care providers should carefully examine all vials of EPOGEN before use.
CARNITOR (levocarnitine)
Tablets, Oral Solution & Injection, made by Sigma-Tau, now lists precautions
for individuals with renal disease. As noted in our May/June
2002 HIV Nutrition Update, many specialized medical beverages for renal
patients contain added carnitine. The safety and efficacy of oral levocarnitine
has not been evaluated in people with renal insufficiency and high doses
of the product in these patients may result in accumulation of potentially
toxic metabolites. It is unknown whether specialized medical beverages
containing carnitine may pose the same risk but caution in the use of these
products seems prudent.
LIPITOR (atorvastatin calcium) Tablets, noted in the Med Watch column
in HIV Nutrition Update Issue
32, is manufactured by Pfizer. Labeling changes, Indications, and Usage
reflect the updated NCEP treatment Guidelines table.
MEGACE (megestrol acetate) Oral Suspension, covered in
Issue
8 of the HIV ReSource Review and discussed in several subsequent issues,
is produced by Bristol Myers Squibb. Labeling
changes for this product now note a revision of the third paragraph
in the Warnings section. Specifically, "The glucocorticoid activity of
MEGACE Oral Suspension has not been fully evaluated. Clinical cases of
new onset diabetes mellitus, exacerbation of pre-existing diabetes mellitus,
and overt Cushing's syndrome have been reported in association with the
chronic use of MEGACE. In addition, clinical cases of adrenal insufficiency
have been observed in patients receiving or being withdrawn from chronic
MEGACE therapy in the stressed and non-stressed state. Furthermore, adrenocorticotropin
(ACTH) stimulation testing has revealed the frequent occurrence of asymptomatic
pituitary-adrenal suppression in patients treated with chronic MEGACE therapy.
Therefore, the possibility of adrenal insufficiency should be considered
in any patient receiving or being withdrawn from chronic MEGACE therapy
who presents with symptoms and/or signs suggestive of hypoadrenalism (e.g.,
hypotension, nausea, vomiting, dizziness, or weakness) in either the stressed
or non-stressed state. Laboratory evaluation for adrenal insufficiency
and consideration of replacement or stress doses of a rapidly acting glucocorticoid
are strongly recommended in such patients. Failure to recognize inhibition
of the hypothalamic-pituitary-adrenal axis may result in death. Finally,
in patients who are receiving or being withdrawn from chronic MEGACE therapy,
consideration should be given to the use of empiric therapy with stress
doses of a rapidly acting glucocorticoid in conditions of stress or serious
intercurrent illness (e.g., surgery, infection).
Global Strategy On Traditional And Alternative Medicine
The World Health Organization (WHO) has launched the first Global
Strategy On Traditional And Alternative Medicine. The information on
this important effort compliments articles on the use of complementary
therapies noted in Issue
21 and Issue 22
of the HIV ReSource Review. Review the WHO
Strategy for Traditional Medicine for 2002-2005.
Canadian HIV/AIDS Policy and Law Review
The latest issue of the Canadian HIV/AIDS Policy and Law Review is
online. Recent events in Canada and
internationally show once again how developments in one country resonate
with those in another, both for good and for ill. Features in this issue
include information on preventing mother-to-child transmission of HIV;
compulsory HIV testing after occupational exposure; safe injection facilities
in Canada; complementary health care; and HIV/AIDS in prisons. Single-issue
print copies of the Review can be obtained from the Canadian HIV/AIDS Clearinghouse
(1565 Carling Avenue, Suite 400, Ottawa ON, K1Z 8R1); tel: 877/999-7740
or 613/725-3434; fax: 613/725-1205. |
|
| Return to Top |
HIV Nutrition News Update - Iss. 2, No. 20
May 17, 2002
Clinical Trials
Studies show that non-Hispanic blacks and Hispanics are less likely
to participate in medication trials. It's interesting that HIV-positive
patients enrolled in private health maintenance organizations (HMOs) may
be less likely to participate in medication trials
than those patients with fee-for-service insurance.
Having access to information on clinical trials is vital to increase
trial participation of these ethnic groups. Canadian
HIV/AIDS Clinical Trials have included:
... CTN 141 - PEG-IFN/Ribavirin/ddI/3TC for HIV/HCV- This study
examined the safety and antiviral effect of a combination of drugs chosen
to eliminate the hepatitis C virus while controlling the HIV resulting
in an increased chance of tolerating future highly active antiretroviral
therapy (HAART). Dr. Marina Klein in Montreal; Dr. Emil Toma in Montreal;
Dr. Anita Rachlis in Toronto; and Dr. Jonathan Angel in Ottawa took part
in the study.
... CTN 157 - Fenofibate (Lipid Supra) & L-Carnitine (Carnitor)
for Elevated Triglycerides- This study was designed to assess two approaches
in managing hypertriglyceridemia or elevated triglyceride levels in the
blood. Fenofibrate and its combination with L-carnitine was compared for
their safety and efficacy in lowering the amount of triglycerides in the
blood.
Participants received nutritional advice from a dietitian to reduce
the risk of diet being a contributing factor in increasing triglycerides.
At certain sites, a substudy also assessed the effect of the two approaches
on fasting blood cholesterol, C-peptide (residue in the formation of insulin)
and insulin levels. Investigators were those named above in addition to
Dr. Walter Schlech in Halifax; Dr. Fiona Smaill in Hamilton; Dr. Sharon
Walmsley in Toronto; Dr. François Laplante in Montreal; Alain Piché
in Sherbrooke; Dr. Julian Falutz in Montreal; Dr. Richard Lalonde in Victoria;
and Dr. Réjean Thomas in Montreal.
Heart Disease and Antiretrovirals
We know that antiretrovirals result
in changes in lipid and sugar metabolism. As noted in our previous
updates, these symptoms overlap risk factors for heart disease and are
a growing concern. Diet
and exercise can help to deal with lipodystrophy. Issue
22 and Issue 23
note how people can deal with these issues through dietary measures. A
recent anecdotal report published in the February issue of Clinical
Infectious Diseases also notes that diet and exercise may help to lessen
the effects of lipodystrophy.
Bone Diseases
Resources on bone disorders are increasing as reports of osteoporosis
(depletion of bone mineral), osteopenia (mild to moderate bone mineral
depletion), and bone death (avascular necrosis) become more common. Recent
publications add to the information presented in our HIV ReSource Review
interview
with Dr. Mary Romeyn and previous updates. San Francisco AIDS Foundation
tells us more about avascular
necrosis (AVN). The New England Journal of Medicine offers Perspective:
Bisphosphonates and Osteoporosis by C.G. Solomon and The
Body offers a variety of information on bone problems.
Substance Abuse, Iron and Hepatitis
Research on injection drug users
adds to the information presented in Issue
24 and Issue 25 of the HIV ReSource Review featuring articles on substance
abuse and HIV-positive people. Investigators at Johns Hopkins University
in Baltimore, Maryland recently found that iron
deficiency is common among female injection drug users. As noted in
Issue
29 and Issue
30 of the HIV ReSource Review, iron supplementation may not be advisable
for individuals with both HIV and hepatitis C infection. Semba notes studies
suggest HIV progression with iron supplementation and iron overload. It
is questionable as to whether the benefits of iron supplementation outweigh
the potential risks.
Reference
1) Semba Rd, Shah N, Strathdee SA, Vlahov D. Brief Report: High Prevalence
of Iron Deficiency and Anemia Among Female Injection Drug Users With and
Without HIV Infection. J Acquir Immune Defic Syndr 2002;29:142-144.
|
|
| Return to Top |
|
HIV Nutrition News Update is a free weekly
review of news related to
nutrition and HIV/AIDS sponsored by A1WebServer and HIV ReSources,
Incorporated. It summarizes recent scientific reports and news related
to nutrition and the field of HIV/AIDS.
See information about HIV ReSources.
To Subscribe or Unsubscribe
Visit HIV
Nutrition News Update List
Copyright HIV ReSources, Inc. All materials
are protected by copyright and are the property of HIV ReSources or the
parties credited as the provider of the content. This copyright notice
must be used when reproducing any portion of the update:
From The HIV Nutrition News Update, Copyright 2002 HIV
ReSources, Incorporated.
Disclaimer
Information in the HIV Nutrition News Update should not be construed
as an endorsement of any kind. Comments are offered for general guidance
only. The information is not intended to replace professional medical advice.
Any use of the information is done strictly on your own risk and no responsibility
is implied or intended on the part of HIV ReSources Inc., the editors,
authors, or the publisher. Discuss any lifestyle changes you may be considering
with
your physician/health care specialist.
|
|
HIV ReSources, Inc.
PO Box 39385
Fort Lauderdale, FL
33339-9385
USA
|
|
Copyright 2002-2007 HIV ReSources, Inc.
Archived 6/11/03
|
|
|
Updated/Reformatted 7/22/07
|
|
|
| |
Electronic
Archive Menu or return back via
your browser's back arrow. |
Return to Top |